GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Cash Receipts from Loans

GeNeuro (FRA:GEM) Cash Receipts from Loans


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


GeNeuro Business Description

Industry
Traded in Other Exchanges
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).